Non-syndromic Retinitis Pigmentosa Panel
Non-syndromic Retinitis Pigmentosa Panel
Normaler Preis
€29.00 EUR
Normaler Preis
Verkaufspreis
€29.00 EUR
Grundpreis
pro
Verfügbarkeit für Abholungen konnte nicht geladen werden
This product is only meant for customers who already purchased a MyGenome Test
Non-syndromic Retinitis Pigmentosa is a rare genetic condition that causes progressive vision loss and can lead to blindness. This panel analyzes genes associated with the condition, allowing for early detection and personalized treatment options for patients. This can benefit individuals who are experiencing symptoms of vision loss, as well as those with a family history of the condition, by providing them with information that can help guide their healthcare decisions.
This panel is recommended for individuals experiencing symptoms of vision loss or with a family history of Non-syndromic Retinitis Pigmentosa. The test can provide patients and their families with information that can help guide their healthcare decisions, including personalized treatment options and the potential for early detection. Early diagnosis can help prevent complications and improve patient outcomes.
The analysis takes into consideration the mutation of germline DNA, it investigates SNP and Indel mutations up to 150 bp.
List of main conditions:
Vollständige Details anzeigen
Non-syndromic Retinitis Pigmentosa is a rare genetic condition that causes progressive vision loss and can lead to blindness. This panel analyzes genes associated with the condition, allowing for early detection and personalized treatment options for patients. This can benefit individuals who are experiencing symptoms of vision loss, as well as those with a family history of the condition, by providing them with information that can help guide their healthcare decisions.
This panel is recommended for individuals experiencing symptoms of vision loss or with a family history of Non-syndromic Retinitis Pigmentosa. The test can provide patients and their families with information that can help guide their healthcare decisions, including personalized treatment options and the potential for early detection. Early diagnosis can help prevent complications and improve patient outcomes.
The analysis takes into consideration the mutation of germline DNA, it investigates SNP and Indel mutations up to 150 bp.
- Available in less than 24 hours
- Based on Whole Genome Sequencing
- More than 75 genes analyzed
- Investigates SNP and Indel mutations up to 150 bp
List of main conditions:
- Non-syndromic Retinitis Pigmentosa
Dieses Produkt ist nur für Kunden gedacht, die bereits einen MyGenome-Test erworben haben.